Literature DB >> 15464755

Galanin over-expression decreases the development of neuropathic pain-like behaviors in mice after partial sciatic nerve injury.

Karin Hygge-Blakeman1, Pablo Brumovsky, Jing-Xia Hao, Xiao-Jun Xu, Tomas Hökfelt, Jacqueline N Crawley, Zsuzsanna Wiesenfeld-Hallin.   

Abstract

The neuropeptide galanin may have a role in modulation of nociception, particularly after peripheral nerve injury. Here we assessed the development of neuropathic pain-like behaviors in mice overexpressing galanin under the dopamine beta-hydroxylase promoter. Unoperated galanin over-expressing mice exhibited a moderately reduced sensitivity to noxious heat. Both galanin over-expressing mice and wild-type controls developed mechanical and heat hypersensitivity after photochemically induced partial sciatic nerve ischemic injury. The magnitude and persistence of such pain-like behaviors were significantly less, and recovery was faster in galanin over-expressing mice compared to wild types. However, the recovery from toe-spread deficits did not differ between galanin over-expressing and wild-type mice after a crush injury to the sciatic nerve. Thus, early recovery in pain-like response is unlikely to result from accelerated regeneration in the galanin over-expressing mice. Immunohistochemical analysis showed that galanin is over-expressed both in small and large dorsal root ganglion cells in the transgene mouse, whereas large galanin-positive neurons were never seen in wild-type mice. The present results in general support an inhibitory role of galanin in nociception and indicate that increased availability of galanin in spinal dorsal horn at the time or shortly after nerve injury may reduce the development of pain-like behaviors in mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15464755     DOI: 10.1016/j.brainres.2004.07.078

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

Review 1.  Galanin and its receptors in neurological disorders.

Authors:  Linda Lundström; Anna Elmquist; Tamas Bartfai; Ulo Langel
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

2.  Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2.

Authors:  Cameron S Metcalf; Misty D Smith; Brian D Klein; Daniel R McDougle; Liuyin Zhang; Grzegorz Bulaj
Journal:  Neurochem Res       Date:  2017-04-06       Impact factor: 3.996

3.  Characterisation of the nociceptive phenotype of suppressible galanin overexpressing transgenic mice.

Authors:  Robert J P Pope; Fiona E Holmes; Niall C Kerr; David Wynick
Journal:  Mol Pain       Date:  2010-10-21       Impact factor: 3.395

4.  Gait analysis in normal and spinal contused mice using the TreadScan system.

Authors:  Jason E Beare; Johnny R Morehouse; William H DeVries; Gaby U Enzmann; Darlene A Burke; David S K Magnuson; Scott R Whittemore
Journal:  J Neurotrauma       Date:  2009-11       Impact factor: 5.269

5.  Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models.

Authors:  H Steve White; Erika A Scholl; Brian D Klein; Sean P Flynn; Timothy H Pruess; Brad R Green; Liuyin Zhang; Grzegorz Bulaj
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

6.  CD36 deletion improves recovery from spinal cord injury.

Authors:  Scott A Myers; Kariena R Andres; Theo Hagg; Scott R Whittemore
Journal:  Exp Neurol       Date:  2014-03-30       Impact factor: 5.330

7.  Activation of the galanin receptor 2 in the periphery reverses nerve injury-induced allodynia.

Authors:  Richard P Hulse; David Wynick; Lucy F Donaldson
Journal:  Mol Pain       Date:  2011-04-16       Impact factor: 3.395

8.  Age exacerbates microglial activation, oxidative stress, inflammatory and NOX2 gene expression, and delays functional recovery in a middle-aged rodent model of spinal cord injury.

Authors:  Ramona E von Leden; Guzal Khayrullina; Kasey E Moritz; Kimberly R Byrnes
Journal:  J Neuroinflammation       Date:  2017-08-18       Impact factor: 8.322

9.  Characterization of an enhancer region of the galanin gene that directs expression to the dorsal root ganglion and confers responsiveness to axotomy.

Authors:  Andrea Bacon; Niall C H Kerr; Fiona E Holmes; Kevin Gaston; David Wynick
Journal:  J Neurosci       Date:  2007-06-13       Impact factor: 6.167

Review 10.  Peripheral mechanisms of neuropathic pain - involvement of lysophosphatidic acid receptor-mediated demyelination.

Authors:  Hiroshi Ueda
Journal:  Mol Pain       Date:  2008-04-01       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.